155 related articles for article (PubMed ID: 8956332)
1. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo.
Luessen HL; de Leeuw BJ; Langemeÿer MW; de Boer AB; Verhoef JC; Junginger HE
Pharm Res; 1996 Nov; 13(11):1668-72. PubMed ID: 8956332
[TBL] [Abstract][Full Text] [Related]
2. N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cells) and in vivo (rats).
Thanou M; Florea BI; Langemeÿer MW; Verhoef JC; Junginger HE
Pharm Res; 2000 Jan; 17(1):27-31. PubMed ID: 10714604
[TBL] [Abstract][Full Text] [Related]
3. Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo.
Thanou M; Verhoef JC; Marbach P; Junginger HE
J Pharm Sci; 2000 Jul; 89(7):951-7. PubMed ID: 10861597
[TBL] [Abstract][Full Text] [Related]
4. Chitosan and its derivatives: potential excipients for peroral peptide delivery systems.
Bernkop-Schnürch A
Int J Pharm; 2000 Jan; 194(1):1-13. PubMed ID: 10601680
[TBL] [Abstract][Full Text] [Related]
5. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Luessen HL; de Leeuw BJ; de Boer BG; Verhoef JC; Junginger HE
Pharm Res; 1997 Sep; 14(9):1197-202. PubMed ID: 9327448
[TBL] [Abstract][Full Text] [Related]
6. In vivo buccal delivery of the peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigs.
Hoogstraate AJ; Coos Verhoef J; Pijpers A; van Leengoed LA; Verheijden JH; Junginger HE; Boddé HE
Pharm Res; 1996 Aug; 13(8):1233-7. PubMed ID: 8865318
[TBL] [Abstract][Full Text] [Related]
7. Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo.
Thanou M; Nihot MT; Jansen M; Verhoef JC; Junginger HE
J Pharm Sci; 2001 Jan; 90(1):38-46. PubMed ID: 11064377
[TBL] [Abstract][Full Text] [Related]
8. Chitosan and its derivatives as intestinal absorption enhancers.
Thanou M; Verhoef JC; Junginger HE
Adv Drug Deliv Rev; 2001 Oct; 50 Suppl 1():S91-101. PubMed ID: 11576697
[TBL] [Abstract][Full Text] [Related]
9. Effects of the mucoadhesive polymer polycarbophil on the intestinal absorption of a peptide drug in the rat.
Lehr CM; Bouwstra JA; Kok W; De Boer AG; Tukker JJ; Verhoef JC; Breimer DD; Junginger HE
J Pharm Pharmacol; 1992 May; 44(5):402-7. PubMed ID: 1359054
[TBL] [Abstract][Full Text] [Related]
10. Intestinal absorption of octreotide using trimethyl chitosan chloride: studies in pigs.
Thanou M; Verhoef JC; Verheijden JH; Junginger HE
Pharm Res; 2001 Jun; 18(6):823-8. PubMed ID: 11474787
[TBL] [Abstract][Full Text] [Related]
11. Improvement of nasal bioavailability of luteinizing hormone-releasing hormone agonist, buserelin, by cyclodextrin derivatives in rats.
Matsubara K; Abe K; Irie T; Uekama K
J Pharm Sci; 1995 Nov; 84(11):1295-300. PubMed ID: 8587046
[TBL] [Abstract][Full Text] [Related]
12. Nasal delivery of levonorgestrel for contraception: an experimental study in rats.
Shahiwala A; Misra A
Fertil Steril; 2004 Mar; 81 Suppl 1():893-8. PubMed ID: 15019826
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Thanou MM; Luebetaen HL; de Boer AG; Verhoef JC; Junginger HE
J Pharm Sci; 1999 Feb; 88(2):253-7. PubMed ID: 9950647
[TBL] [Abstract][Full Text] [Related]
14. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
Khan S; Patil K; Yeole P; Gaikwad R
J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
[TBL] [Abstract][Full Text] [Related]
15. Effects of polyacrylic polymers on the degradation of insulin and peptide drugs by chymotrypsin and trypsin.
Bai JP; Chang LL; Guo JH
J Pharm Pharmacol; 1996 Jan; 48(1):17-21. PubMed ID: 8722488
[TBL] [Abstract][Full Text] [Related]
16. Oral drug absorption enhancement by chitosan and its derivatives.
Thanou M; Verhoef JC; Junginger HE
Adv Drug Deliv Rev; 2001 Nov; 52(2):117-26. PubMed ID: 11718935
[TBL] [Abstract][Full Text] [Related]
17. Mucoadhesive nanoparticulate systems for peptide drug delivery.
Takeuchi H; Yamamoto H; Kawashima Y
Adv Drug Deliv Rev; 2001 Mar; 47(1):39-54. PubMed ID: 11251244
[TBL] [Abstract][Full Text] [Related]
18. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
[TBL] [Abstract][Full Text] [Related]
19. Influence of chitosan and polycarbophil on permeation of a model hydrophilic drug into the urinary bladder wall.
Grabnar I; Bogataj M; Mrhar A
Int J Pharm; 2003 Apr; 256(1-2):167-73. PubMed ID: 12695023
[TBL] [Abstract][Full Text] [Related]
20. Prolonged intestinal absorption of cephradine with chitosan-coated ethylcellulose microparticles in rats.
Takishima J; Onishi H; Machida Y
Biol Pharm Bull; 2002 Nov; 25(11):1498-502. PubMed ID: 12419970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
